What question did this study set out to answer?

This meta-analysis aims to determine the global seroprevalence of hepatitis E among individuals living with HIV.

Global seroprevalence of hepatitis E among people living with HIV: a systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Systematic review estimates hepatitis E seroprevalence in people living with HIV, suggesting significant global rates.

This meta-analysis aims to determine the global seroprevalence of hepatitis E among individuals living with HIV.
Conducted systematic review following PRISMA guidelines.
Included 88 studies across different continents.
Estimated seroprevalence using a random-effects model for meta-analysis.
Performed subgroup analyses by continent and income level.
Pooled global seroprevalence of hepatitis E among people living with HIV was 16.0%.
Subgroup analysis revealed seroprevalence of 12.0% in Europe, 24.0% in Asia, 19.0% in Africa, and 11.0% in the Americas.
Notably high prevalence of 37.0% observed in low-income countries.

Magri et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark